Chinese firm to invest $30M in Pluristem

Regenerative medicine company Pluristem Therapeutics Inc. (NASDAQ:PSTI; Tel Aviv:PSTI) said China's Innovative Medical Management Co. Ltd. (SZSE:002173) will invest about $30 million in the company through its purchase of 16.9 million shares at $1.77. Innovative Medical will also receive 4.4 million five-year warrants exercisable at $2.50.

Additionally, Innovative Medical will have one seat on Pluristem's board as long as it holds at least 12.5% of the company's issued and outstanding stock. ...